Table 1.
Clinical characteristics of LrGG with survival information in TCGA and CGGA datasets.
TCGA | CGGA | |
---|---|---|
No. of patients | 511 | 172 |
age (mean, year) | 40.03 | 40.42 |
Gender | ||
Male | 283 | 105 |
Female | 228 | 67 |
Censor | ||
alive | 386 | 122 |
death | 125 | 50 |
WHO grade | ||
G II | 246 | 105 |
G III | 264 | 67 |
unknown | 1 | – |
IDH status | ||
WT | 90 | 44 |
Mut | 411 | 128 |
unknown | 10 | – |
MGMT promoter methylation | – | |
methylated | 416 | – |
unmethylated | 85 | – |
unknown | 10 | – |
karnofsky performance score (KPS) | – | |
>70 | 254 | – |
≤70 | 47 | – |
unknown | 210 | – |